Search results (1320)
« Back to PublicationsDose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Charles Coombes R. et al, (2023), Nat Commun, 14
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Carroll TM. et al, (2023), Cancer Cell, 41, 1222 - 1241.e7
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Kristeleit R. et al, (2023), Br J Cancer, 129, 38 - 45
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
Luke JJ. et al, (2023), Br J Cancer, 128, 2227 - 2235
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study.
Hamid O. et al, (2023), J Immunother Cancer, 11
Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines.
Josa-Culleré L. et al, (2023), Eur J Med Chem, 258
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells
Turkalj S. et al, (2023), Cell Stem Cell, 30, 722 - 740.e11